News

August 21, 2019August 21, 2019

Eli Lilly Launches Challenge for Digital Solutions to Improve IBD Care

News

The pharmaceutical company Eli Lilly has announced an open innovation challenge for individuals, teams, and organizations in the United States to propose digital health solutions that can improve care ... Read more

August 19, 2019August 19, 2019

Smoking Does Not Have Beneficial Effects for UC Patients, Study Shows

News

Despite the popular belief that smoking may provide a protective effect for patients with ulcerative colitis (UC), a recent large-scale study found no benefits from smoking in patients with ... Read more

August 12, 2019August 12, 2019

IBD Patients at Higher Risk of Developing Type 2 Diabetes, Study in Denmark Suggests

News

Patients with inflammatory bowel disease (IBD) are at higher risk of developing type 2 diabetes, compared with the general population, according to a study conducted in Denmark. The study, ... Read more

August 9, 2019August 9, 2019

NP-178 Becomes Algernon’s Lead Candidate for Treating IBD

News

NP-178 (emoxypine), an oral small molecule being repurposed by Algernon Pharmaceuticals, has become the company’s lead candidate to treat inflammatory bowel disease (IBD). Emoxypine is one of the most commercialized ... Read more

August 7, 2019August 7, 2019

Edinburgh has One of the Highest Rates of IBD in the World, Study Reports

News

Edinburgh, in Scotland, has one of the highest recorded rates of inflammatory bowel disease (IBD) in the world, higher than what is currently recognized, a study has found. The ... Read more

August 5, 2019August 5, 2019

Camligo Trial Yields Mixed Results in Patients with Pouchitis

News

Atlantic Healthcare’s Camligo (alicaforsen enema) did not meet the primary endpoints of the Phase 3 clinical trial that aimed to evaluate the efficacy of the drug in patients with ... Read more

August 2, 2019August 2, 2019

Editing Gut Bacteria Reduces Colorectal Cancer in Mice with Colitis

News

Tweaking the types of bacteria living in the gut, or gut microbiota, can prevent bowel cancer in mice with inflammatory bowel disease (IBD), a new study has found. By ... Read more

July 30, 2019July 30, 2019

Clinical Trial in Israel Will Evaluate Cannabidiol-based Product for Crohn’s Disease

News

The Israel-based company Stero Biotechs announced it soon will conduct a study to test a cannabidiol (CBD)-based solution as a potential treatment for steroid-dependent Crohn’s disease (SDCD). SDCD is ... Read more

July 29, 2019July 29, 2019

CHMP Favors Approving Stelara to Treat Moderate to Severe Ulcerative Colitis in EU

News

The Committee for Medicinal Products for Human Use (CHMP), part of the European Medicines Agency (EMA), has recommended that Stelara (ustekinumab) be approved in Europe to treat moderately to severely ... Read more

July 26, 2019July 26, 2019

Hadlima, Biosimilar to Humira, Receives FDA Approval to Treat Autoimmune Diseases

News

Hadlima (adalimumab-bwwd) — an antibody biosimilar to AbbVie‘s Humira (adalimumab) — has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of a number of ... Read more